Editas Medicine, Inc.

Duke University

Penrose O'Donnell

David A Bumcrot

Ari E Friedland

Bryan R Cullen

Shen Shen

Minerva Sanchez

CRISPR/CAS-related systems, compositions and methods for editing RS1, RL2, and/or LAT genes in human cells are described, as are cells and compositions including cells edited according to the same.

CRISPR/CAS-related methods and compositions for treating herpes simplex virus

CRISPR/RNA-guided nuclease-related compositions and methods for treatment of A1AT deficiency and associated conditions are disclosed.

Systems and methods for treating alpha 1-antitrypsin (A1AT) deficiency

Genome editing systems and genetic constructs that target a herpes simplex virus (HSV) viral gene, where the systems comprise one Cas9 molecule, and a gRNA molecule, compositions and cells comprising such genome editing systems and genetic constructs as well as methods for using the genome editing systems, genetic constructs, compositions and cells for genome engineering, and for preventing, treating or reducing HSV infection.

CRISPR/cas-related methods and compositions for treating herpes simplex virus

CRISPR/Cas-related methods and compositions for treating herpes simplex virus

Growing community of inventors

Yarmouth, ME, United States of America

Penrose O'Donnell